Cargando…

The Proton Pump Inhibitor Non-Responder: A Clinical Conundrum

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Hussain, Zilla H, Henderson, Emily E, Maradey-Romerao, Carla, George, Nina, Fass, Ronnie, Lacy, Brian E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816041/ https://www.ncbi.nlm.nih.gov/pubmed/26448456 http://dx.doi.org/10.1038/ctg.2015.45

Ejemplares similares

The Proton Pump Inhibitor Non-Responder: A Clinical Conundrum
por: Hussain, Zilla H, et al.
Publicado: (2015)

New and Future Drug Development for Gastroesophageal Reflux Disease
por: Maradey-Romero, Carla, et al.
Publicado: (2014)

Comparison of Clinical Characteristics of Patients With Gastroesophageal Reflux Disease Who Failed Proton Pump Inhibitor Therapy Versus Those Who Fully Responded
por: Dickman, Ram, et al.
Publicado: (2011)

Sa143 THE RISK OF COVID-19 IS HIGHER IN FEMALES USING PROTON PUMP INHIBITORS
por: Ghoneim, Sara, et al.
Publicado: (2021)

Unmet Needs in the Treatment of Gastroesophageal Reflux Disease
por: Dickman, Ram, et al.
Publicado: (2015)

Reducing the Inappropriate Use of Proton Pump Inhibitors in an Internal Medicine Residency Clinic
por: Boster, Joshua, et al.
Publicado: (2020)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Validation of the Reflux Symptom Questionnaire Electronic Diary in Partial Responders to Proton Pump Inhibitor Therapy
por: Vakil, Nimish, et al.
Publicado: (2012)

Effect of the transcutaneous electrical stimulation system on esophageal-acid exposure in patients non-responsive to once-daily proton-pump inhibitor: proof-of-concept study
por: Dickman, Ram, et al.
Publicado: (2021)

Corrigendum to ‘How Iran responded to expanding need for laboratory services for COVID-19?’
por: Salehi-Vaziri, Mostafa, et al.
Publicado: (2021)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Corrigendum to: Contemporary outcomes of cardiac surgery patients supported by the intra-aortic balloon pump
Publicado: (2022)

Development of an Oral Push–Pull Osmotic Pump of Fenofibrate-Loaded Mesoporous Silica Nanoparticles [Corrigendum]
Publicado: (2022)

The Association of Diuretics and Proton Pump Inhibitors With Chondrocalcinosis
por: Felson, David T., et al.
Publicado: (2021)

Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders
por: Humaidan, P., et al.
Publicado: (2017)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

Use and overuse of proton pump inhibitors
por: Staiano, Annamaria, et al.
Publicado: (2015)

Symptomatic hypomagnesemia and proton pump inhibitors
por: Tin, Sim Sai, et al.
Publicado: (2014)

Corrigendum to: Determinants of left atrial reservoir and pump strain and use of atrial strain for evaluation of left ventricular filling pressure
por: Inoue, Katsuji, et al.
Publicado: (2021)

Prescribing efficiency of proton pump inhibitors in China: influence and future directions
por: Zeng, Wenjie, et al.
Publicado: (2015)

Do Proton Pump Inhibitors Decrease Calcium Absorption?
por: Hansen, Karen E, et al.
Publicado: (2010)

Adverse Effects Associated with Proton Pump Inhibitor Use
por: Yibirin, Marcel, et al.
Publicado: (2021)

Use of Proton Pump Inhibitors and the Risk of Hospitalization for Infectious Gastroenteritis
por: Chen, Yingxi, et al.
Publicado: (2016)

Proton pump inhibitors alter the composition of the gut microbiota
por: Jackson, Matthew A, et al.
Publicado: (2016)

Risk of Pyogenic Liver Abscess in Proton Pump Inhibitor Users: New Inventory of Proton Pump Inhibitor Induced Complications?
por: Bang, Ki Bae
Publicado: (2021)

Deprescribing Strategies: A Prospective Study on Proton Pump Inhibitors
por: Calvini, Giulia, et al.
Publicado: (2023)

Daily or weekly dosing with EGFR inhibitors, gefitinib and lapatinib, and AKT inhibitor MK2206 in mammary cancer models
por: Lubet, Ronald A., et al.
Publicado: (2019)

Helicobacter pylori, proton pump inhibitors and gastroesophageal reflux disease.
por: Kuipers, E. J., et al.
Publicado: (1999)

General Theory of Inflammation: Patient Self-Administration of Hydrocortisone Safely Achieves Superior Control of Hydrocortisone-Responding Disorders by Matching Dosage with Symptom Intensity [Corrigendum]
Publicado: (2020)

General Theory of Inflammation: Patient Self-Administration of Hydrocortisone Safely Achieves Superior Control of Hydrocortisone-Responding Disorders by Matching Dosage with Symptom Intensity [Corrigendum]
Publicado: (2023)

Proton Pump Inhibitors Use and Risk of Preeclampsia: A Meta-Analysis
por: Hussain, Salman, et al.
Publicado: (2022)

Management of laryngopharyngeal reflux with proton pump inhibitors
por: Reimer, Christina, et al.
Publicado: (2008)

Proton Pump Inhibitor Induced Depigmentation in Vitiligo
por: Holla, Anantha Prasad, et al.
Publicado: (2011)

Proton pump inhibitor-induced hypomagnesemic hypoparathyroidism
por: Swaminathan, Krishnan
Publicado: (2015)

Proton pump inhibitors: A balanced view
por: Ramakrishna, B.S.
Publicado: (2015)

Proton Pump Inhibitors: The Culprit for Barrett’s Esophagus?
por: Alsalahi, Omran, et al.
Publicado: (2015)

Proton pump inhibitors affect the gut microbiome
por: Imhann, Floris, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_acd081v02717ou63dqm2poc0q2